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Introduction 30
Cantú syndrome is a rare genetic autosomal dominant disorder caused by dominant gain-of-function 31 mutations in the ATP-dependent potassium channel subunits ABCC9 (Harakalova et Recent breakthroughs in solving atomic and near-atomic resolution structures of eukaryotic inward 38 rectifier potassium channels provide an excellent opportunity to investigate the structural basis of CS 39 mutations and for developing novel therapies for KATP channelopathies. Starting from January 2017, 40 the first (near-)atomic resolution structures (resolution ranges from 3.63 Å to 6.3 Å) of these hetero- 41 octameric complexes have been solved by cryo-EM microscopy by three independent labs (Lee et al., 42 2017; Li et al., 2017; Martin et al., 2017a Martin et al., , 2017b Wu et al., 2018) . These structures confirm that KATP 43 channels are formed by four Kir6.x pore-forming subunits and four regulatory sulfonylurea receptor 44 (SUR) subunits. 45 KATP channels couple the metabolic state of the cell to membrane excitability and play a key role in 46 physiological processes such as insulin secretion in the pancreas (Ashcroft, 2005) , protection of cardiac 47 muscle during ischemia (Crawford et al., 2002; Nichols and Lederer, 1991; Zingman et al., 2007) and 48 hypoxic vasodilation of arterial smooth muscle cells (Dart and Standen, 1995 Nichols, 2009 ). Further, SUR2 subunits have been shown to play a role in human neurological disease, 59
including prevalent diseases of the aged brain (Nelson et al., 2015 and MacKinnon, 2011)) as template. A sequence alignment is shown in Supplementary Figure 1A . The 100 root mean square deviation (RMSD) of the Kir6.1 model converged to ~ 4 Å at around 100 ns, 101
indicating that the simulated systems are stable and at equilibrium (see Supplementary Figure 1C ). RSG for short, full atomistic molecular dynamics simulations were performed. Specifically, the 114 binding was probed by adding 20 molecules (10 x S conformer, 10 x R conformer, since the prescribed 115 drug is a racemic mixture) randomly into the solvent, leading to an effective drug concentration of ~ 116 170 mM. As seen in Figure 1 , 13 ligands partition into the lipid membrane within 1,5 s. Three out of 117 20 molecules occupied sites close to the protein for 1.3 -1.5 s (see Table 1 ). The three major binding 118 sites ( Figure 2 ) identified are: close to the PIP2 binding site, denoted site A; the interface between two 119 cytoplasmic domains (CTDs), denoted site B, and between the -sheet D and the G-G loop, 120 denoted site C. 121
Binding site A is of particular interest since the ligand binds close to the transmembrane gate and the 122 PIP2 binding site. Binding includes mainly hydrophobic interactions with residue LEU57 and ILE60. 123
Additionally, hydrophobic and hydrogen bond interactions with POPC lipid molecules are observed.
Even though PIP2 is within 5 Å of ligand no specific interactions with RSG are observed. All residues 125 within 6 Å of ligand are shown in Figure 2C . Given the importance of this area for channel gating 126 (Zhang et al., 2015) , we decided to perform a more exhaustive sampling of this region. We therefore 127 used computationally less demanding docking simulations with both compounds, followed by 250 ns 128 MD simulations of the best-scored pose for RSG, and 200 ns of the best-scored pose for N-RSG. This 129 way, strengthened binding interactions (defined as increased accessible surface area: 0.9 nm 2 for site 130 A vs. 3 nm 2 when using the best docking pose) were obtained. We refer to this new site A as site A_ref. 131
To further characterize the three binding sites, the potential of mean force (PMF) of the ligands at site 132
A_ref, B and C, were calculated using umbrella sampling (US) simulations. As can be seen in Figure  133 3, the PMFs reveal clear differences between the three sites. Binding of RSG to site A_ref is most 134 favorable. Since PMF calculations reveal shallow binding for ligands bound at sites B and C, we did 135 not further investigate these two binding sites. Nevertheless, ligand binding site B, might be potentially 136
interesting, since intersubunit interactions in this region have been shown previously to be important 137
for the inactivation process in Kir6. with the binding site throughout the trajectory. More than 75% of the frames contain hydrophobic 146
interactions between the Ring A and residue PHE76, VAL172 and MET173, and between the Linker 147 E and TRP69. Residues LEU64, ILE75, PHE80, ILE168 and ILE169 also frequently formed 148 hydrophobic interactions with RSG ( Figure 4B ). The interaction map of N-RSG molecule reveals a 149 similar trend indicating mainly hydrophobic interactions with the binding site (see Supplementary  150 Figure 2). Both ligands also form hydrogen bonds with POPC lipid molecules, which are not included 151 in the interaction map calculations. 152 153
Structure based dynamic pharmacophore models of RSG binding to site A_ref 154
Understanding the inhibition mechanisms of the pore-forming Kir6.1 subunit could be a first step to 155 develop novel blockers for the treatment of rare disease causing mutations (e.g. Cantú mutations 156 V64M), which are not amenable for sulfonylurea therapy (Cooper et al., 2017) . In line with this 157 reasoning we constructed dynamic structure-based pharmacophore models and screened for hits in 158
DrugBank (Law et al., 2014) , which contains all marketed drugs, by using the common hits approach 159 (CHA) (Wieder et al., 2017) . Structure-based pharmacophore models were generated using 5,000 160 frames from the MD simulation, which included the lipid bilayer but omitted solvent molecules. 161
Pharmacophore models, which contain common pharmacophore features and identical involved ligand 162 atoms, are considered as one representative pharmacophore model. Five representative pharmacophore 163 models (Model 1 -5) were observed from the frames (shown in Supplementary Figure 3 showed that these channels are insensitive to RSG. Thus, we performed a multiple sequence alignment 194 of these channels and evaluated the conservation of the predicted binding site residues. As shown in 195 Figure 6 , differences between Kir6. Proposed mechanism of drug action 219 RSG binds at the interface between two subunits, very close to PIP2, an essential gating modulator of 220 inward rectifier channels. It is conceivable that the drug interferes with normal channel activation, 221
possibly via "blocking" the activation gate and/or via hindering normal lipid modulation of channels. 222
In line with this reasoning, we observed frequent hydrogen bonds to lipid molecules in our simulations. 223
Further simulations, using different lipid types will be necessary in the future to investigate this 224 possibility. In addition, the predicted binding site A_ref is in close proximity of two previously 225
identified RSG binding site, we constructed dynamic pharmacophore models using the recently introduced 255 common hits approach and screened for hits in DrugBank, which contains all drugs available on the 256 market. Functional testing confirmed three new high affinity blockers, with different chemical 257 scaffolds (see Figure 5 ). The identified compounds (see Table 2 The sequence alignments can be found in Supplementary Figure 1A . with the steepest descent algorithm, followed by a 6 ns equilibration simulation. 1.5 s unbiased MD 293 simulations were performed to detect the ligand binding sites. Additionally, 200 ns MD simulations 294
were run from the best docking pose of the ligand. 295 296 Docking 297 RSG was docked at the putative binding site identified from unbiased MD simulations, using the 298 program Gold4.0.1 (Jones et al., 1997) . The binding sites identified in the 1.5 s free MD simulations 299
were used as starting point and the radius was set to 20 Å. 100,000 operations of the GOLD genetic 300 algorithm were used to dock the compounds with the ChemPLP scoring function. 301 302
Umbrella sampling (US) 303
In order to estimate the ligand binding affinity, we performed US at each binding site. Ligands were 304
firstly pulled into the solvent using the pull code in GROMACS by applying a harmonic biasing force 305 between the center of mass (COM) of ligand and the COM of binding site (defined by residues within 306 5 Å of the ligand). The initial systems were taken from the last frames of the MD simulations for 307 binding sites A_ref, B and C. To ensure that the ligands were pulled along the reaction coordinates 308 fully into the solvent area, a harmonic force of 1,000 kJ/(mol·nm 2 ) was applied for most of the pulling 309 simulations. In cases, where the ligand displayed high mobility during the pulling trajectories, the 310 harmonic force was increased to 2,000 kJ/(mol·nm 2 ). Starting configurations for US were chosen from 311 the pulling trajectories by taking steps every 0.1 nm along the reaction coordinates. Several 312 intermediate windows were added if the adjacent US windows did not overlap sufficiently. Harmonic 313 forces of 500, 1,000, 2,000 or 3,000 kJ/(mol·nm 2 ) were applied to restrict the ligands during US 314 sampling. For each window, a 10 ns simulation was performed, excluding the first 1 ns as equilibration. 315
In total, 242 windows were simulated. Thus, in total, 2.42 s simulations were performed to obtain 316 good US window overlaps (Supplementary Figure 4) . The potential of mean forces (PMF) were 317 calculated by using weighted histogram analysis method (WHAM) (Hub et al., 2010) and the statistical 318 errors were estimated by 100 times bootstrap analysis (Efron, 1979 Representative pharmacophore models were obtained by merging all identical features, extracted from 332 the 5,000 frames. In the end, five representative pharmacophore models were used for virtual screening 333 against DrugBank4.0 (Law et al., 2014) (see Supplementary Figure 3 ). The molecules in DrugBank 334
were prepared as libraries for virtual screening using the LigandScout command line tool idbgen. 335 Conformers for each molecule in the database were generated using the icon best option in idbgen; this 336 option produces a maximum number of 200 conformations for each molecule processed. The CHA 337 produced a ranked hit-list for the binding site. The approved drugs that fits at least two of the five 338
representative pharmacophore models were proposed in the final hit-list shown in Table 2 . 339 340
Interaction map 341
The interactions of RSG and N-RSG at site A_ref (only protein and PIP2 were considered) over the 342 200 ns MD simulations were analyzed and quantified by interaction maps, which were generated by 343 the python package matplotlib (Hunter, 2007) Inside-out patch clamp electrophysiology was performed as described previously (Harakalova et al., 356 2012). In short, HEK293T cells were cultured on 10 mm glass coverslips and transfected with 0.16 g 357 of rat pCMV6-Kir6.2, 0.16 g of rat pCMV6-SUR2A and 0.08 g of pEGFP1 expression constructs. 358
Measurements were performed using an AxoPatch 200B amplifier controlled by pClamp 9 software 359 (Molecular Devices) at 22 °C using a ramp protocol ranging from -100 to +100 mV in 5 s from a 360 holding potential of -40 mV. 
